"Receptors, Androgen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
| Descriptor ID |
D011944
|
| MeSH Number(s) |
D12.776.826.750.150
|
| Concept/Terms |
Receptors, Androgen- Receptors, Androgen
- Androgen Receptor
- Receptor, Androgen
- Androgen Receptors
- Dihydrotestosterone Receptors
- Testosterone Receptor
- Receptors, Androgens
- Androgens Receptors
- Receptors, Dihydrotestosterone
- Receptors, Stanolone
- Stanolone Receptors
- Stanolone Receptor
- Receptor, Stanolone
- 5 alpha-Dihydrotestosterone Receptor
- 5 alpha Dihydrotestosterone Receptor
- Receptor, 5 alpha-Dihydrotestosterone
- alpha-Dihydrotestosterone Receptor, 5
- Receptor, Testosterone
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Androgen".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Androgen".
This graph shows the total number of publications written about "Receptors, Androgen" by people in this website by year, and whether "Receptors, Androgen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 1 | 4 |
| 2000 | 3 | 0 | 3 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 0 | 2 |
| 2003 | 8 | 1 | 9 |
| 2004 | 4 | 4 | 8 |
| 2005 | 4 | 3 | 7 |
| 2006 | 3 | 2 | 5 |
| 2007 | 3 | 6 | 9 |
| 2008 | 5 | 1 | 6 |
| 2009 | 4 | 3 | 7 |
| 2010 | 0 | 5 | 5 |
| 2011 | 7 | 3 | 10 |
| 2012 | 5 | 2 | 7 |
| 2013 | 7 | 4 | 11 |
| 2014 | 9 | 4 | 13 |
| 2015 | 8 | 2 | 10 |
| 2016 | 8 | 5 | 13 |
| 2017 | 3 | 3 | 6 |
| 2018 | 7 | 2 | 9 |
| 2019 | 3 | 2 | 5 |
| 2020 | 10 | 2 | 12 |
| 2021 | 7 | 2 | 9 |
| 2022 | 6 | 4 | 10 |
| 2023 | 2 | 5 | 7 |
| 2024 | 5 | 2 | 7 |
| 2025 | 3 | 3 | 6 |
| 2026 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Androgen" by people in Profiles.
-
Identification of CAND1 as a DNA-dependent protein kinase-regulated coactivator of androgen receptor and the ARv7 splice variant. PLoS One. 2026; 21(5):e0349130.
-
Breaking the bonds: targeting protein dimerization for prostate cancer therapy. Endocrinology. 2026 May 06; 167(6).
-
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma. Nature. 2026 04; 652(8110):763-773.
-
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer. Int J Clin Oncol. 2025 Dec; 30(12):2635-2642.
-
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study. Int J Clin Oncol. 2025 Sep; 30(9):1858-1865.
-
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer. Endocr Relat Cancer. 2025 Jun 01; 32(6).
-
Paving the path ForwARd: Advances and challenges in androgen receptor targeting in breast cancer. Cancer Treat Rev. 2025 Jul; 138:102958.
-
Androgen receptor ubiquitination links KCTD13 to genitourinary tract defects. FASEB J. 2025 Feb 28; 39(4):e70406.
-
Role of Kctd13 in modulating AR and SOX9 expression in different penile cell populations. Andrology. 2025 Jul; 13(5):1201-1212.
-
Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2. Sci Signal. 2024 12 17; 17(867):eadk4122.